ISSN 2997-2833 - (Pending)

Coffee with the expert

Prof. Peter J. Hotez

The Hotez times in Public Health

Summer hit the United States Congress and it’s inferno hot in public health. Coincidentally, we had the privilege to have a candid conversation with Prof. Peter Hotez, M.D., Ph.D., Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, who shared his perspectives on many important health issues.

Letter from the editors

Welcome to Vaccines Beat

Dear colleagues, Welcome to the inaugural issue of Vaccines Beat, your go-to source for all updates in vaccinology.  Our aim is to provide an innovative and comprehensive global perspective on vaccines, vaccination, vaccine introduction to NIPs;...

News & Alerts

Highlights Issue 001

A summary of the latest News & Alerts in the fields of vaccinology, vaccines, vaccination, and vaccine-preventable diseases. We curate the latest information on regulatory updates, emerging trends, breakthroughs in vaccine technology, vaccine safety and efficacy, global immunization developments and outbreak alerts, as a resource to keep our community informed.


Latest published papers and commentaries from the chief editors

Latest impactful scientific publications that stand out for their potential bearing on healthcare. We introduce groundbreaking research findings, innovative treatment modalities, results from phase 1 to 3 vaccine clinical trials, or paradigm-shifting discoveries that redefine our understanding of infectious diseases and therapeutic approaches for all vaccine-preventable diseases.


Vaccine against Chikungunya: good news, a vaccine has been aproved by the Food and...

Recently, a phase 3 clinical trial published at The Lancet showed high immunogenicity and good safety profile of a one shot of a live attenuated Chikungunya (CHIK) vaccine (1), leading to further look for...


One dose of Human Papilloma Virus vaccine as a global strategy to prevent...

Even though Human Papilloma Virus (HPV) causes cancer in several epithelia, the priority purpose of HPV massive immunization is the prevention of cervical cancer in women, which accounts for 82% of all HPV-related cancers...


How new vaccines are developed

The U.S. Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER) is responsible for regulating vaccine use in the United States. The general stages of vaccine development are: Research and Discovery Proof of Concept ...


The potential for a new Lyme disease vaccine

Growing need for proactive measures Lyme disease, caused by Borrelia burgdorferi transmitted through infected Ixodes ticks, is the most prevalent vector-borne infectious disease in the Northern hemisphere (1), often leading to long-lasting consequences. The United...


Download newsletter

Download this month’s newsletter in pdf format



Events calendar